| ER4 Stock | | | EUR 5.25 0.08 1.50% |
President
Ms. Katherine Strei is Executive Vice President and Chief Human Resources Officer of the company since April 2017. Ms. Strei became executive vice president of corporate communications in March 2018. She previously served as senior vice president and chief human resources officer from January 2016 to March 2017. Prior to joining us, Ms. Strei was an independent consultant, specializing in leadership and organization development from February 2014 to January 2016. Ms. Strei has extensive experience in human resource leadership roles, having previously served as vice president of global leadership and organization development at MedImmune from June 2005 to January 2014, director of executive development at the Federal National Mortgage Association from May 1999 to May 2005, and program director, director of training, as well as corporate manager for ManorCare Health Services from August 1992 to May 1999. Ms. Strei received a B.A. in Sociology from Lawrence University and an M.S. in Organization Development from American UniversityNTL Institute. Ms. Strei also holds a certificate for Leadership Coaching from Georgetown University. since 2017.
EMERGENT BIOSOLUT (ER4) is traded on Berlin Exchange in Germany and employs 18 people.
EMERGENT BIOSOLUT Leadership Team
Elected by the shareholders, the EMERGENT BIOSOLUT's board of directors comprises two types of representatives: EMERGENT BIOSOLUT inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EMERGENT. The board's role is to monitor EMERGENT BIOSOLUT's management team and ensure that shareholders' interests are well served. EMERGENT BIOSOLUT's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EMERGENT BIOSOLUT's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Kramer, CFO, Interim Executive Vice President - Corporate Services Division, Principal Financial and Accounting Officer, Treasurer | |
| Sean Kirk, Executive Vice President Manufacturing and Technical Operations | |
| Katherine Strei, Executive Vice President, Human Resources and Communications, Chief Human Resources Officer | |
| Fuad ElHibri, Executive Chairman of the Board | |
| Sue Bailey, Independent Director | |
| Jerome Hauer, Independent Director | |
| Marvin White, Director | |
| Kathryn Zoon, Independent Director | |
| Atul Saran, Executive Vice President Corporate Development, General Counsel and Corporate Secretary | |
| Seamus Mulligan, Director | |
| George Joulwan, Independent Director | |
| Adam Havey, Executive Vice President and Presidentident - BioDefense Division | |
| Louis Sullivan, Independent Director | |
| Ronald Richard, Lead Independent Director | |
| Zsolt Harsanyi, Independent Director | |
| Richard Lindahl, Chief Financial Officer, Executive Vice President, Treasurer | |
EMERGENT Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EMERGENT BIOSOLUT a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in EMERGENT Stock
EMERGENT BIOSOLUT financial ratios help investors to determine whether EMERGENT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EMERGENT with respect to the benefits of owning EMERGENT BIOSOLUT security.